Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Gains from Investment Securities (2022 - 2025)

Bioregenx's Gains from Investment Securities history spans 4 years, with the latest figure at $47.3 million for Q2 2025.

  • Quarterly results put Gains from Investment Securities at $47.3 million for Q2 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $212571.0 (down 4.06% YoY), and the annual figure for FY2025 was $43.1 million, down 8.85%.
  • Gains from Investment Securities for Q2 2025 was $47.3 million at Bioregenx, up from $7.9 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $47.3 million in Q2 2025 to a low of -$79400.0 in Q2 2022.
  • The 4-year median for Gains from Investment Securities is $29700.0 (2022), against an average of $6.3 million.
  • The sharpest move saw Gains from Investment Securities plummeted 349.02% in 2023, then skyrocketed 15674.8% in 2024.
  • Year by year, Gains from Investment Securities stood at $39000.0 in 2022, then surged by 575.31% to $263371.0 in 2023, then skyrocketed by 2904.13% to $7.9 million in 2024, then soared by 497.92% to $47.3 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $47.3 million, $7.9 million, and $7.9 million for Q2 2025, Q3 2024, and Q1 2024 respectively.